Attenuation of Aβ toxicity by promotion of mitochondrial fusion in neuroblastoma cells by liquiritigenin

Doo Sin Jo, Dong Woon Shin, So Jung Park, Ji Eun Bae, Joon Bum Kim, Na Yeon Park, Jae Sung Kim, Jeong Su Oh, Jung Won Shin, Dong Hyung Cho

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations

Abstract

Mitochondrial dynamics control mitochondrial morphology and function, and aberrations in these are associated with various neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease. To identify novel regulators of mitochondrial dynamics, we screened a phytochemical library and identified liquiritigenin as a potent inducer of mitochondrial fusion. Treatment with liquiritigenin induced an elongated mitochondrial morphology in SK-N-MC cells. In addition, liquiritigenin rescued mitochondrial fragmentation induced by knockout of mitochondrial fusion mediators such as Mfn1, Mfn2, and Opa1. Furthermore, we found that treatment with liquiritigenin notably inhibited mitochondrial fragmentation and cytotoxicity induced by Aβ in SK-N-MC cells.

Original languageEnglish
Pages (from-to)1137-1143
Number of pages7
JournalArchives of Pharmacal Research
Volume39
Issue number8
DOIs
StatePublished - 1 Aug 2016

Keywords

  • Amyloid beta
  • Fusion/fission
  • Liquiritigenin
  • Mitochondria dynamics

Fingerprint

Dive into the research topics of 'Attenuation of Aβ toxicity by promotion of mitochondrial fusion in neuroblastoma cells by liquiritigenin'. Together they form a unique fingerprint.

Cite this